Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants.

Ben-Sheetrit, Joseph; Hermon, Yehonathan; Birkenfeld, Shlomo; Gutman, Yehiel; Csoka, Antonei B; Toren, Paz

Ben-Sheetrit, Joseph; Hermon, Yehonathan; Birkenfeld, Shlomo; Gutman, Yehiel; Csoka, Antonei B; Toren, Paz.

Afiliação

Ben-Sheetrit J; Tel-Aviv Brüll Community Mental Health Center, Clalit Health Services, 9 Hatzvi St., 6719709, Tel-Aviv, Israel.
Hermon Y; Geha Mental Health Center, Petah Tikva, Israel.
Birkenfeld S; Tel-Aviv Brüll Community Mental Health Center, Clalit Health Services, 9 Hatzvi St., 6719709, Tel-Aviv, Israel. Jhonathan.h@gmail.com.
Gutman Y; Clalit Health Services, Tel-Aviv, Israel.
Csoka AB; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Toren P; Clalit Health Services, Tel-Aviv, Israel.

Ann Gen Psychiatry ; 22(1): 15, 2023 Apr 21.

Article em En | MEDLINE | ID: mdl-37085865

Palavras-chave

Erectile Dysfunction (ED); Post-SSRI Sexual Dysfunction (PSSD); Selective Serotonin Reuptake Inhibitors (SSRIs); Serotonergic Antidepressants

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Ann Gen Psychiatry Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google